CNBC updated the headline after the fact.
The panel initially voted to reject the booster. Afterwards, they held a second vote in which the panel approved the booster for 65+.
The panel initially voted to reject the booster. Afterwards, they held a second vote in which the panel approved the booster for 65+.
No comments yet.